Samuel D. Colella, Director, 10% Owner at Flexion Therapeutics Inc (FLXN), bought 10,000 shares at $16.38 ($164K) on 2016-12-01, disclosed to the SEC on 2016-12-05.
Open-market purchase of $164k FLXN by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| FLDM | BUY | 2019-08-12 | $7K | — | Filing → |
| FLXN | BUY | 2019-08-09 | $21K | — | Filing → |
| FLDM | BUY | 2019-08-08 | $63K | — | Filing → |